NEW DELHI (Reuters) - Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to meet the drug regulator's demand for ...

About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel ...

Pfizer will lay off 1,700 employees and cease manufacturing “immediately” at two plants in India, according to The Hindu Business Line. “Pfizer has conducted a thorough evaluation of the ...

Track Pfizer share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...

Indian Sites From Pfizer, Wockhardt Face Complications After GMP Inspections Pfizer and Wockhardt are struggling to keep pace with pharmaceutical good manufacturing practice (GMP) regulations as two ...

MUMBAI (Reuters) - Pfizer Ltd(NSI:PFIZER.NS - News), the Indian unit of U.S. drug maker Pfizer Inc (NYS:PFE - News), is to take over local affiliate Wyeth Ltd (NSI:WYETH.NS - News), they said on ...

Pfizer India and Cipla announced a partnership on Friday in which Cipla will exclusively market and distribute four Pfizer brands in India to increase their reach. These include cough syrups Corex Dx ...

Cipla Ltd. has inked an exclusive agreement with Pfizer India to market, distribute, and sell the latter's four brands across the country. Under the agreement, Cipla now has the sole right to market, ...